← Back
Data updated: Mar 10, 2026
COHERUS BIOSCIENCES INC
ImmunologyGastroenterologyOncology
COHERUS BIOSCIENCES INC is a biotechnology company focused on Immunology, Gastroenterology, Oncology.
2018
Since
3
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 33%
1 drugs
Gastroenterology 33%
1 drugs
Oncology 33%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Immunology, Gastroenterology
ASTELLAS specialty
Oncology, Gastroenterology, Immunology